Standard BioTools (STU:FLB) Other Net Income (Loss) : €-0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Standard BioTools Other Net Income (Loss)?

Standard BioTools's Other Net Income (Loss) for the three months ended in Mar. 2024 was €0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.0 Mil.

Standard BioTools's quarterly Other Net Income (Loss) declined from Sep. 2023 (€0.0 Mil) to Dec. 2023 (€-0.0 Mil) but then increased from Dec. 2023 (€-0.0 Mil) to Mar. 2024 (€0.0 Mil).

Standard BioTools's annual Other Net Income (Loss) declined from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€-0.0 Mil) but then increased from Dec. 2022 (€-0.0 Mil) to Dec. 2023 (€-0.0 Mil).

Standard BioTools Other Net Income (Loss) Historical Data

The historical data trend for Standard BioTools's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard BioTools Other Net Income (Loss) Chart

Standard BioTools Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Standard BioTools Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Standard BioTools Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.0 Mil.

Standard BioTools Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Standard BioTools's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Standard BioTools (STU:FLB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Standard BioTools Inc (STU:FLB) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

LAB:USA FLB:Germany

Address

2 Tower Place, Suite 2000, South San Francisco, CA, USA, 94080

Website

https://www.standardbio.com

Standard BioTools Inc manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. The company's segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Standard BioTools (STU:FLB) Headlines

No Headlines